These findings from the present study indicate that overexpressed UBE2C, mediated by dysregulated promoter methylation level and suppression of hsa-miR-193b-3p degradation, may serve as a promising diagnostic or prognostic biomarker for HCC. The gene discussed is UBE2C; the disease is hepatocellular carcinoma.